Acute Device-Related Thrombus after Watchman Device Implant

Atrial fibrillation is characterized by irregularly irregular heart rhythm with an increased morbidity and mortality. It is associated with an increased risk of thromboembolism due to formation of blood clot in the left atrium. Most of these blood clots are formed in the left atrial appendage. The r...

Full description

Bibliographic Details
Main Authors: Muhammad Ajmal, Vijendra Swarup
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2019/8397561
id doaj-f957e14ac99246cc9215419de80aaccf
record_format Article
spelling doaj-f957e14ac99246cc9215419de80aaccf2020-11-24T21:27:49ZengHindawi LimitedCase Reports in Cardiology2090-64042090-64122019-01-01201910.1155/2019/83975618397561Acute Device-Related Thrombus after Watchman Device ImplantMuhammad Ajmal0Vijendra Swarup1St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USASt. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USAAtrial fibrillation is characterized by irregularly irregular heart rhythm with an increased morbidity and mortality. It is associated with an increased risk of thromboembolism due to formation of blood clot in the left atrium. Most of these blood clots are formed in the left atrial appendage. The risk of blood clot formation is reduced with the use of anticoagulants. The patients who cannot take anticoagulants due to an increased bleeding risk can undergo percutaneous left atrial appendage (LAA) closure. A Watchman device is used for this purpose. LAA closure with the Watchman device is associated with some adverse effects, and one of them is device-related thrombus. Currently, there are no specific guidelines for the management of device-related thrombus. We present a case of Watchman device-related thrombus which developed 16 hours after the device placement. We will also discuss various options for the management of acute thrombosis.http://dx.doi.org/10.1155/2019/8397561
collection DOAJ
language English
format Article
sources DOAJ
author Muhammad Ajmal
Vijendra Swarup
spellingShingle Muhammad Ajmal
Vijendra Swarup
Acute Device-Related Thrombus after Watchman Device Implant
Case Reports in Cardiology
author_facet Muhammad Ajmal
Vijendra Swarup
author_sort Muhammad Ajmal
title Acute Device-Related Thrombus after Watchman Device Implant
title_short Acute Device-Related Thrombus after Watchman Device Implant
title_full Acute Device-Related Thrombus after Watchman Device Implant
title_fullStr Acute Device-Related Thrombus after Watchman Device Implant
title_full_unstemmed Acute Device-Related Thrombus after Watchman Device Implant
title_sort acute device-related thrombus after watchman device implant
publisher Hindawi Limited
series Case Reports in Cardiology
issn 2090-6404
2090-6412
publishDate 2019-01-01
description Atrial fibrillation is characterized by irregularly irregular heart rhythm with an increased morbidity and mortality. It is associated with an increased risk of thromboembolism due to formation of blood clot in the left atrium. Most of these blood clots are formed in the left atrial appendage. The risk of blood clot formation is reduced with the use of anticoagulants. The patients who cannot take anticoagulants due to an increased bleeding risk can undergo percutaneous left atrial appendage (LAA) closure. A Watchman device is used for this purpose. LAA closure with the Watchman device is associated with some adverse effects, and one of them is device-related thrombus. Currently, there are no specific guidelines for the management of device-related thrombus. We present a case of Watchman device-related thrombus which developed 16 hours after the device placement. We will also discuss various options for the management of acute thrombosis.
url http://dx.doi.org/10.1155/2019/8397561
work_keys_str_mv AT muhammadajmal acutedevicerelatedthrombusafterwatchmandeviceimplant
AT vijendraswarup acutedevicerelatedthrombusafterwatchmandeviceimplant
_version_ 1725973248103940096